Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Avicanna Inc. AVCNF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Avicanna Inc. (AVCNF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.11. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $25M, +130.1%/yr average growth. Net income is $4M (loss), growing at +37.1%/yr. Net profit margin is -14.2% (negative). Gross margin is 50.7% (-35.9 pp trend).

Balance sheet: total debt is $109,227 against $2M equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 0.82 (tight liquidity). Debt-to-assets is 0.5%. Total assets: $20M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 35/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

AVCNF SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 35/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AVCNF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
100/100
AVCNF: +130.1%/yr revenue is, +37.1%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet AVCNF: Debt-to-Equity (D/E) ratio 0.05 (conservative), Current ratio is 0.82 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
35/100
AVCNF: Gross margin is 50.7% (-35.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 35/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
AVCNF: Net profit margin is -14.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.102-0.236
Volume500
Avg Volume (30D)43.74K
Market Cap$14.33M
Beta (1Y)1.28
Share Statistics
EPS (TTM)-0.04
Shares Outstanding$100.03M
IPO Date2021-01-08
Employees87
CEOAras Azadian Mba
Financial Highlights & Ratios
Revenue (TTM)$25.46M
Gross Profit$12.9M
EBITDA$-2.43M
Net Income$-3.62M
Operating Income$-4.68M
Total Cash$448.03K
Total Debt$109.23K
Net Debt$-338.8K
Total Assets$20.12M
Price / Earnings (P/E)-3.2
Price / Sales (P/S)0.56
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA05368K1003

Price Chart

Track all markets on TradingView
AVCNF
Avicanna Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.10 52WK RANGE 0.24

People Also View

CNTMF
CNTMF
Cansortium Inc.
$0.04
+3.09%
 PCLOF
PCLOF
PharmaCielo Ltd.
$0.03
-7.67%
 FFNTF
FFNTF
4Front Ventures Corp.
$0.00
+0.00%
 FLOOF
FLOOF
Flower One Holdings Inc.
$0.00
+0.00%
 KHRNF
KHRNF
Khiron Life Sciences Corp.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message